Suppr超能文献

他汀类药物对骨骼肌的影响:物理治疗师的视角。

Effects of statins on skeletal muscle: a perspective for physical therapists.

机构信息

University of Delaware, Newark, Delaware, USA.

出版信息

Phys Ther. 2010 Oct;90(10):1530-42. doi: 10.2522/ptj.20090251. Epub 2010 Aug 5.

Abstract

Hyperlipidemia, also known as high blood cholesterol, is a cardiovascular health risk that affects more than one third of adults in the United States. Statins are commonly prescribed and successful lipid-lowering medications that reduce the risks associated with cardiovascular disease. The side effects most commonly associated with statin use involve muscle cramping, soreness, fatigue, weakness, and, in rare cases, rapid muscle breakdown that can lead to death. Often, these side effects can become apparent during or after strenuous bouts of exercise. Although the mechanisms by which statins affect muscle performance are not entirely understood, recent research has identified some common causative factors. As musculoskeletal and exercise specialists, physical therapists have a unique opportunity to identify adverse effects related to statin use. The purposes of this perspective article are: (1) to review the metabolism and mechanisms of actions of statins, (2) to discuss the effects of statins on skeletal muscle function, (3) to detail the clinical presentation of statin-induced myopathies, (4) to outline the testing used to diagnose statin-induced myopathies, and (5) to introduce a role for the physical therapist for the screening and detection of suspected statin-induced skeletal muscle myopathy.

摘要

高脂血症,也称为高血胆固醇,是一种心血管健康风险,影响了超过三分之一的美国成年人。他汀类药物是常用的处方和成功的降脂药物,可降低与心血管疾病相关的风险。最常与他汀类药物使用相关的副作用包括肌肉痉挛、疼痛、疲劳、虚弱,在极少数情况下,还会出现迅速的肌肉分解,从而导致死亡。这些副作用通常在剧烈运动期间或之后出现。尽管他汀类药物影响肌肉性能的机制尚不完全清楚,但最近的研究已经确定了一些常见的致病因素。作为肌肉骨骼和运动专家,物理治疗师有机会识别与他汀类药物使用相关的不良反应。本文的目的是:(1)综述他汀类药物的代谢和作用机制,(2)讨论他汀类药物对骨骼肌功能的影响,(3)详细介绍他汀类药物诱导的肌病的临床表现,(4)概述用于诊断他汀类药物诱导的肌病的检测方法,(5)引入物理治疗师在筛查和检测疑似他汀类药物诱导的骨骼肌肌病中的作用。

相似文献

1
Effects of statins on skeletal muscle: a perspective for physical therapists.
Phys Ther. 2010 Oct;90(10):1530-42. doi: 10.2522/ptj.20090251. Epub 2010 Aug 5.
2
Statin induced myopathy.
J Insur Med. 2009;41(2):132-5.
3
Statin myopathy: a review of recent progress.
Curr Opin Rheumatol. 2010 Nov;22(6):644-50. doi: 10.1097/BOR.0b013e32833f0fc7.
4
Statin-associated myopathy.
JAMA. 2003 Apr 2;289(13):1681-90. doi: 10.1001/jama.289.13.1681.
6
Modeling statin myopathy in a human skeletal muscle microphysiological system.
PLoS One. 2020 Nov 25;15(11):e0242422. doi: 10.1371/journal.pone.0242422. eCollection 2020.
7
Mechanisms of statin-associated skeletal muscle-associated symptoms.
Pharmacol Res. 2020 Apr;154:104201. doi: 10.1016/j.phrs.2019.03.010. Epub 2019 Mar 12.
8
Statin-induced apoptosis and skeletal myopathy.
Am J Physiol Cell Physiol. 2006 Dec;291(6):C1208-12. doi: 10.1152/ajpcell.00226.2006. Epub 2006 Aug 2.
9
Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes.
Exerc Sport Sci Rev. 2012 Oct;40(4):188-94. doi: 10.1097/JES.0b013e31826c169e.
10
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
Int J Mol Sci. 2021 Oct 28;22(21):11687. doi: 10.3390/ijms222111687.

引用本文的文献

1
Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesis.
Front Pharmacol. 2025 Aug 13;16:1562587. doi: 10.3389/fphar.2025.1562587. eCollection 2025.
3
The evidence and impact of deprescribing on sarcopenia parameters: a systematic review.
BMC Geriatr. 2025 Mar 7;25(1):158. doi: 10.1186/s12877-025-05819-7.
4
Role of Statins in Oral and Maxillofacial Surgery: A Literature Review.
Cureus. 2024 Sep 19;16(9):e69746. doi: 10.7759/cureus.69746. eCollection 2024 Sep.
5
Exome Sequencing and Statin Treatment Response in 64,000 UK Biobank Patients.
Int J Mol Sci. 2024 Apr 17;25(8):4426. doi: 10.3390/ijms25084426.
6
The effect of statins on falls and physical activity in people aged 65 and older: A systematic review.
Eur J Clin Pharmacol. 2024 May;80(5):657-668. doi: 10.1007/s00228-024-03632-6. Epub 2024 Feb 14.
7
A Comprehensive Review of Modifiable Cardiovascular Risk Factors and Genetic Influences in Dementia Prevention.
Cureus. 2023 Nov 7;15(11):e48430. doi: 10.7759/cureus.48430. eCollection 2023 Nov.
8
Targeting ferroptosis opens new avenues for the development of novel therapeutics.
Signal Transduct Target Ther. 2023 Sep 21;8(1):372. doi: 10.1038/s41392-023-01606-1.
9
Antibiotics and Lipid-Modifying Agents: Potential Drug-Drug Interactions and Their Clinical Implications.
Pharmacy (Basel). 2023 Aug 19;11(4):130. doi: 10.3390/pharmacy11040130.
10
Correlates of Myopathy in Diabetic Patients Taking Statins.
Cureus. 2023 Apr 17;15(4):e37708. doi: 10.7759/cureus.37708. eCollection 2023 Apr.

本文引用的文献

3
Genetic predisposition to statin myopathy.
Curr Opin Rheumatol. 2008 Nov;20(6):648-55. doi: 10.1097/BOR.0b013e328314b7b4.
4
Drug-induced myopathies.
Curr Opin Neurol. 2008 Oct;21(5):590-5. doi: 10.1097/WCO.0b013e32830e2774.
5
Statin myopathy as a metabolic muscle disease.
Expert Rev Cardiovasc Ther. 2008 Aug;6(7):971-8. doi: 10.1586/14779072.6.7.971.
7
Molecular basis of statin-associated myopathy.
Atherosclerosis. 2009 Jan;202(1):18-28. doi: 10.1016/j.atherosclerosis.2008.05.021. Epub 2008 May 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验